Skip to main content
SpringerLink
Log in
Book cover

Meningitis and Encephalitis pp 5–25Cite as

Community-Acquired Acute Bacterial Meningitis

  • Chapter
  • First Online:

  • 1236 Accesses

Abstract

Community-acquired acute bacterial meningitis is a fulminant disease with a mortality of 10–30% and high risk for permanent neurologic or hearing deficit [1,2,3,4]. It is one of the most urgent treatable conditions because the patients may deteriorate to coma and death within 24–72 h, and early adequate treatment is pivotal for survival and a favorable outcome.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Glimaker M, Johansson B, Grindborg O, Bottai M, Lindquist L, Sjolin J. Adult bacterial meningitis: earlier treatment and improved outcome following guideline revision promoting prompt lumbar puncture. Clin Infect Dis. 2015;60(8):1162–9.

    Article  CAS  PubMed  Google Scholar 

  2. Koster-Rasmussen R, Korshin A, Meyer CN. Antibiotic treatment delay and outcome in acute bacterial meningitis. J Infect. 2008;57(6):449–54.

    Article  PubMed  Google Scholar 

  3. Thigpen MC, Whitney CG, Messonnier NE, et al. Bacterial meningitis in the United States, 1998-2007. N Engl J Med. 2011;364(21):2016–25.

    Article  CAS  PubMed  Google Scholar 

  4. van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med. 2004;351(18):1849–59.

    Article  PubMed  Google Scholar 

  5. van Ettekoven CN, van de Beek D, Brouwer MC. Update on community-acquired bacterial meningitis: guidance and challenges. Clin Microbiol Infect. 2017;23(9):601–6.

    Article  PubMed  Google Scholar 

  6. Polkowska A, Toropainen M, Ollgren J, Lyytikainen O, Nuorti JP. Bacterial meningitis in Finland, 1995-2014: a population-based observational study. BMJ Open. 2017;7(5):e015080.

    Article  PubMed  PubMed Central  Google Scholar 

  7. De Gaudio M, Chiappini E, Galli L, De Martino M. Therapeutic management of bacterial meningitis in children: a systematic review and comparison of published guidelines from a European perspective. J Chemother. 2010;22(4):226–37.

    Article  Google Scholar 

  8. Ouchenir L, Renaud C, Khan S, et al. The epidemiology, management, and outcomes of bacterial meningitis in infants. Pediatrics. 2017;140(1):e20170476.

    Article  PubMed  Google Scholar 

  9. Joubrel C, Tazi A, Six A, et al. Group B streptococcus neonatal invasive infections, France 2007-2012. Clin Microbiol Infect. 2015;21(10):910–6.

    Article  CAS  PubMed  Google Scholar 

  10. Weisfelt M, van de Beek D, Spanjaard L, Reitsma JB, de Gans J. Community-acquired bacterial meningitis in older people. J Am Geriatr Soc. 2006;54(10):1500–7.

    Article  PubMed  Google Scholar 

  11. Koopmans MM, Bijlsma MW, Brouwer MC, van de Beek D, van der Ende A. Listeria monocytogenes meningitis in the Netherlands, 1985-2014: a nationwide surveillance study. J Infect. 2017;75(1):12–9.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Perera N, Abulhoul L, Green MR, Swann RA. Group A streptococcal meningitis: case report and review of the literature. J Infect. 2005;51(2):E1–4.

    Article  PubMed  Google Scholar 

  13. Aguilar J, Urday-Cornejo V, Donabedian S, Perri M, Tibbetts R, Zervos M. Staphylococcus aureus meningitis: case series and literature review. Medicine (Baltimore). 2010;89(2):117–25.

    Article  Google Scholar 

  14. Doran KS, Fulde M, Gratz N, et al. Host-pathogen interactions in bacterial meningitis. Acta Neuropathol. 2016;131(2):185–209.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Edberg M, Furebring M, Sjolin J, Enblad P. Neurointensive care of patients with severe community-acquired meningitis. Acta Anaesthesiol Scand. 2011;55(6):732–9.

    Article  CAS  PubMed  Google Scholar 

  16. Grände PO, Myhre EB, Nordström CH, Schliamser S. Treatment of intracranial hypertension and aspects on lumbar dural puncture in severe bacterial meningitis. Acta Anaesthesiol Scand. 2002;46(3):264–70.

    Article  PubMed  Google Scholar 

  17. Lindvall P, Ahlm C, Ericsson M, Gothefors L, Naredi S, Koskinen LO. Reducing intracranial pressure may increase survival among patients with bacterial meningitis. Clin Infect Dis. 2004;38(3):384–90.

    Article  PubMed  Google Scholar 

  18. Durand ML, Calderwood SB, Weber DJ, et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med. 1993;328(1):21–8.

    Article  CAS  PubMed  Google Scholar 

  19. Horwitz SJ, Boxerbaum B, O’Bell J. Cerebral herniation in bacterial meningitis in childhood. Ann Neurol. 1980;7(6):524–8.

    Article  CAS  PubMed  Google Scholar 

  20. Kramer AH, Bleck TP. Neurocritical care of patients with central nervous system infections. Curr Treat Options Neurol. 2008;10(3):201–11.

    Article  PubMed  Google Scholar 

  21. Glimaker M, Johansson B, Halldorsdottir H, et al. Neuro-intensive treatment targeting intracranial hypertension improves outcome in severe bacterial meningitis: an intervention-control study. PLoS One. 2014;9(3):e91976.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Leib SL, Tauber MG. Pathogenesis of bacterial meningitis. Infect Dis Clin N Am. 1999;13(3):527–48, v–vi.

    Article  CAS  Google Scholar 

  23. Scheld WM, Koedel U, Nathan B, Pfister HW. Pathophysiology of bacterial meningitis: mechanism(s) of neuronal injury. J Infect Dis. 2002;186(Suppl 2):S225–33.

    Article  CAS  PubMed  Google Scholar 

  24. Helweg-Larsen J, Astradsson A, Richhall H, Erdal J, Laursen A, Brennum J. Pyogenic brain abscess, a 15 year survey. BMC Infect Dis. 2012;12:332.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Schliamser SE, Bäckman K, Norrby SR. Intracranial abscesses in adults: an analysis of 54 consecutive cases. Scand J Infect Dis. 1988;20(1):1–9.

    Article  CAS  PubMed  Google Scholar 

  26. Jaijakul S, Arias CA, Hossain M, Arduino RC, Wootton SH, Hasbun R. Toscana meningoencephalitis: a comparison to other viral central nervous system infections. J Clin Virol. 2012;55(3):204–8.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Best J, Hughes S. Evidence behind the WHO Guidelines: hospital care for children – what are the useful clinical features of bacterial meningitis found in infants and children? J Trop Pediatr. 2008;54(2):83–6.

    Article  PubMed  Google Scholar 

  28. McGill F, Heyderman RS, Michael BD, et al. The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults. J Infect. 2016;72(4):405–38.

    Article  CAS  PubMed  Google Scholar 

  29. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004;39(9):1267–84.

    Article  PubMed  Google Scholar 

  30. van de Beek D, Cabellos C, Dzupova O, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016;22(Suppl 3):S37–62.

    Article  PubMed  Google Scholar 

  31. Khumalo J, Nicol M, Hardie D, Muloiwa R, Mteshana P, Bamford C. Diagnostic accuracy of two multiplex real-time polymerase chain reaction assays for the diagnosis of meningitis in children in a resource-limited setting. PLoS One. 2017;12(3):e0173948.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Leber AL, Everhart K, Balada-Llasat JM, et al. Multicenter evaluation of BioFire FilmArray meningitis/encephalitis panel for detection of bacteria, viruses, and yeast in cerebrospinal fluid specimens. J Clin Microbiol. 2016;54(9):2251–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Brouwer MC, Thwaites GE, Tunkel AR, van de Beek D. Dilemmas in the diagnosis of acute community-acquired bacterial meningitis. Lancet. 2012;380(9854):1684–92.

    Article  PubMed  Google Scholar 

  34. Glimaker M, Johansson B, Bell M, et al. Early lumbar puncture in adult bacterial meningitis-rationale for revised guidelines. Scand J Infect Dis. 2013;45(9):657–63.

    Article  PubMed  Google Scholar 

  35. Joffe AR. Lumbar puncture and brain herniation in acute bacterial meningitis: a review. J Intensive Care Med. 2007;22(4):194–207.

    Article  PubMed  Google Scholar 

  36. Radetsky M. Fulminant bacterial meningitis. Pediatr Infect Dis J. 2014;33(2):204–7.

    Article  PubMed  Google Scholar 

  37. Kastenbauer S, Winkler F, Pfister HW. Cranial CT before lumbar puncture in suspected meningitis. N Engl J Med. 2002;346(16):1248–51. author reply -51.

    Article  PubMed  Google Scholar 

  38. van Crevel H, Hijdra A, de Gans J. Lumbar puncture and the risk of herniation: when should we first perform CT? J Neurol. 2002;249(2):129–37.

    Article  PubMed  Google Scholar 

  39. Costerus JM, Brouwer MC, van der Ende A, van de Beek D. Community-acquired bacterial meningitis in adults with cancer or a history of cancer. Neurology. 2016;86(9):860–6.

    Article  PubMed  Google Scholar 

  40. Salazar L, Hasbun R. Cranial imaging before lumbar puncture in adults with community-acquired meningitis: clinical utility and adherence to the Infectious Diseases Society of America guidelines. Clin Infect Dis. 2017;64(12):1657–62.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Costerus JM, Brouwer MC, Bijlsma MW, Tanck MW, van der Ende A, van de Beek D. Impact of an evidence-based guideline on the management of community-acquired bacterial meningitis: a prospective cohort study. Clin Microbiol Infect. 2016;22(11):928–33.

    Article  CAS  PubMed  Google Scholar 

  42. Proulx N, Fréchette D, Toye B, Chan J, Kravcik S. Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis. QJM. 2005;98(4):291–8.

    Article  CAS  PubMed  Google Scholar 

  43. Aronin SI, Peduzzi P, Quagliarello VJ. Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing. Ann Intern Med. 1998;129(11):862–9.

    Article  CAS  PubMed  Google Scholar 

  44. Hasbun R, Abrahams J, Jekel J, Quagliarello VJ. Computed tomography of the head before lumbar puncture in adults with suspected meningitis. N Engl J Med. 2001;345(24):1727–33.

    Article  CAS  PubMed  Google Scholar 

  45. Kanegaye JT, Soliemanzadeh P, Bradley JS. Lumbar puncture in pediatric bacterial meningitis: defining the time interval for recovery of cerebrospinal fluid pathogens after parenteral antibiotic pretreatment. Pediatrics. 2001;108(5):1169–74.

    PubMed  CAS  Google Scholar 

  46. Michael B, Menezes BF, Cunniffe J, et al. Effect of delayed lumbar punctures on the diagnosis of acute bacterial meningitis in adults. Emerg Med J. 2010;27(6):433–8.

    Article  PubMed  Google Scholar 

  47. Prasad K, Singhal T, Jain N, Gupta PK. Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis. Cochrane Database Syst Rev. 2004;(2):Cd001832.

    Google Scholar 

  48. Lebel MH, Hoyt MJ, McCracken GH Jr. Comparative efficacy of ceftriaxone and cefuroxime for treatment of bacterial meningitis. J Pediatr. 1989;114(6):1049–54.

    Article  CAS  PubMed  Google Scholar 

  49. Peltola H, Anttila M, Renkonen OV. Randomised comparison of chloramphenicol, ampicillin, cefotaxime, and ceftriaxone for childhood bacterial meningitis. Finnish Study Group. Lancet. 1989;1(8650):1281–7.

    Article  CAS  PubMed  Google Scholar 

  50. del Rio MA, Chrane D, Shelton S, McCracken GH Jr, Nelson JD. Ceftriaxone versus ampicillin and chloramphenicol for treatment of bacterial meningitis in children. Lancet. 1983;1(8336):1241–4.

    PubMed  Google Scholar 

  51. Odio CM, Faingezicht I, Salas JL, Guevara J, Mohs E, McCracken GH Jr. Cefotaxime vs. conventional therapy for the treatment of bacterial meningitis of infants and children. Pediatr Infect Dis. 1986;5(4):402–7.

    Article  CAS  PubMed  Google Scholar 

  52. Schaad UB, Suter S, Gianella-Borradori A, et al. A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children. N Engl J Med. 1990;322(3):141–7.

    Article  CAS  PubMed  Google Scholar 

  53. Klugman KP, Dagan R. Randomized comparison of meropenem with cefotaxime for treatment of bacterial meningitis. Meropenem Meningitis Study Group. Antimicrob Agents Chemother. 1995;39(5):1140–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Saez-Llorens X, Castano E, Garcia R, et al. Prospective randomized comparison of cefepime and cefotaxime for treatment of bacterial meningitis in infants and children. Antimicrob Agents Chemother. 1995;39(4):937–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Schmutzhard E, Williams KJ, Vukmirovits G, Chmelik V, Pfausler B, Featherstone A. A randomised comparison of meropenem with cefotaxime or ceftriaxone for the treatment of bacterial meningitis in adults. Meropenem Meningitis Study Group. J Antimicrob Chemother. 1995;36(Suppl A):85–97.

    Article  CAS  PubMed  Google Scholar 

  56. Scholz H, Hofmann T, Noack R, Edwards DJ, Stoeckel K. Prospective comparison of ceftriaxone and cefotaxime for the short-term treatment of bacterial meningitis in children. Chemotherapy. 1998;44(2):142–7.

    Article  CAS  PubMed  Google Scholar 

  57. Odio CM, Puig JR, Feris JM, et al. Prospective, randomized, investigator-blinded study of the efficacy and safety of meropenem vs. cefotaxime therapy in bacterial meningitis in children. Meropenem Meningitis Study Group. Pediatr Infect Dis J. 1999;18(7):581–90.

    Article  CAS  PubMed  Google Scholar 

  58. Saez-Llorens X, McCoig C, Feris JM, et al. Quinolone treatment for pediatric bacterial meningitis: a comparative study of trovafloxacin and ceftriaxone with or without vancomycin. Pediatr Infect Dis J. 2002;21(1):14–22.

    Article  PubMed  Google Scholar 

  59. Baldwin CM, Lyseng-Williamson KA, Keam SJ. Meropenem: a review of its use in the treatment of serious bacterial infections. Drugs. 2008;68(6):803–38.

    Article  CAS  PubMed  Google Scholar 

  60. Ntziora F, Falagas ME. Linezolid for the treatment of patients with central nervous system infection. Ann Pharmacother. 2007;41(2):296–308.

    Article  CAS  PubMed  Google Scholar 

  61. Cottagnoud PH, Tauber MG. New therapies for pneumococcal meningitis. Expert Opin Investig Drugs. 2004;13(4):393–401.

    Article  CAS  PubMed  Google Scholar 

  62. Nau R, Djukic M, Spreer A, Ribes S, Eiffert H. Bacterial meningitis: an update of new treatment options. Expert Rev Anti-Infect Ther. 2015;13(11):1401–23.

    Article  CAS  PubMed  Google Scholar 

  63. Bretonniere C, Jozwiak M, Girault C, et al. Rifampin use in acute community-acquired meningitis in intensive care units: the French retrospective cohort ACAM-ICU study. Crit Care. 2015;19:303.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Tauber MG, Khayam-Bashi H, Sande MA. Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis. J Infect Dis. 1985;151(3):528–34.

    Article  CAS  PubMed  Google Scholar 

  65. Brouwer MC, McIntyre P, Prasad K, van de Beek D. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015;(9):CD004405.

    Google Scholar 

  66. de Gans J, van de Beek D, European Dexamethasone in Adulthood Bacterial Meningitis Study I. Dexamethasone in adults with bacterial meningitis. N Engl J Med. 2002;347(20):1549–56.

    Article  PubMed  Google Scholar 

  67. Molyneux EM, Walsh AL, Forsyth H, et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet. 2002;360(9328):211–8.

    Article  CAS  PubMed  Google Scholar 

  68. Nguyen TH, Tran TH, Thwaites G, et al. Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. N Engl J Med. 2007;357(24):2431–40.

    Article  CAS  PubMed  Google Scholar 

  69. Peltola H, Roine I, Fernandez J, et al. Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double-blind, placebo-controlled trial. Clin Infect Dis. 2007;45(10):1277–86.

    Article  CAS  PubMed  Google Scholar 

  70. Scarborough M, Gordon SB, Whitty CJ, et al. Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa. N Engl J Med. 2007;357(24):2441–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. McIntyre PB, Berkey CS, King SM, et al. Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988. JAMA. 1997;278(11):925–31.

    Article  CAS  PubMed  Google Scholar 

  72. Glimaker M, Brink M, Naucler P, Sjolin J. Betamethasone and dexamethasone in adult community-acquired bacterial meningitis: a quality registry study from 1995 to 2014. Clin Microbiol Infect. 2016;22(9):814 e1–7.

    Article  CAS  Google Scholar 

  73. Costerus JM, Brouwer MC, van der Ende A, van de Beek D. Repeat lumbar puncture in adults with bacterial meningitis. Clin Microbiol Infect. 2016;22(5):428–33.

    Article  CAS  PubMed  Google Scholar 

  74. Bijlsma MW, Brouwer MC, Kasanmoentalib ES, et al. Community-acquired bacterial meningitis in adults in the Netherlands, 2006-14: a prospective cohort study. Lancet Infect Dis. 2016;16(3):339–47.

    Article  PubMed  Google Scholar 

  75. Heckenberg SG, Brouwer MC, van der Ende A, van de Beek D. Adjunctive dexamethasone in adults with meningococcal meningitis. Neurology. 2012;79(15):1563–9.

    Article  CAS  PubMed  Google Scholar 

  76. Ogunlesi TA, Odigwe CC, Oladapo OT. Adjuvant corticosteroids for reducing death in neonatal bacterial meningitis. Cochrane Database Syst Rev. 2015;(11):Cd010435.

    Google Scholar 

  77. Syrogiannopoulos GA, Lourida AN, Theodoridou MC, et al. Dexamethasone therapy for bacterial meningitis in children: 2- versus 4-day regimen. J Infect Dis. 1994;169(4):853–8.

    Article  CAS  PubMed  Google Scholar 

  78. Schutte CM, van der Meyden CH. A prospective study of Glasgow Coma Scale (GCS), age, CSF-neutrophil count, and CSF-protein and glucose levels as prognostic indicators in 100 adult patients with meningitis. J Infect. 1998;37(2):112–5.

    Article  CAS  PubMed  Google Scholar 

  79. Merkelbach S, Rohn S, Konig J, Muller M. Usefulness of clinical scores to predict outcome in bacterial meningitis. Infection. 1999;27(4–5):239–43.

    Article  CAS  PubMed  Google Scholar 

  80. van de Beek D, de Gans J, Tunkel AR, Wijdicks EFM. Community-acquired bacterial meningitis in adults. N Engl J Med. 2006;354(1):44–53.

    Article  PubMed  Google Scholar 

  81. van de Beek D, Brouwer MC, Thwaites GE, Tunkel AR. Advances in treatment of bacterial meningitis. Lancet. 2012;380(9854):1693–702.

    Article  PubMed  Google Scholar 

  82. Abulhasan YB, Al-Jehani H, Valiquette MA, et al. Lumbar drainage for the treatment of severe bacterial meningitis. Neurocrit Care. 2013;19(2):199–205.

    Article  PubMed  Google Scholar 

  83. Ajdukiewicz KM, Cartwright KE, Scarborough M, et al. Glycerol adjuvant therapy in adults with bacterial meningitis in a high HIV seroprevalence setting in Malawi: a double-blind, randomised controlled trial. Lancet Infect Dis. 2011;11(4):293–300.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Larsen L, Poulsen FR, Nielsen TH, Nordstrom CH, Schulz MK, Andersen AB. Use of intracranial pressure monitoring in bacterial meningitis: a 10-year follow up on outcome and intracranial pressure versus head CT scans. Infect Dis (Lond). 2017;49(5):356–64.

    Article  Google Scholar 

  85. Bartek J Jr, Thelin EP, Ghatan PH, Glimaker M, Bellander BM. Neuron-specific enolase is correlated to compromised cerebral metabolism in patients suffering from acute bacterial meningitis; an observational cohort study. PLoS One. 2016;11(3):e0152268.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Grande PO, Romner B. Osmotherapy in brain edema: a questionable therapy. J Neurosurg Anesthesiol. 2012;24(4):407–12.

    Article  PubMed  Google Scholar 

  87. Mourvillier B, Tubach F, van de Beek D, et al. Induced hypothermia in severe bacterial meningitis: a randomized clinical trial. JAMA. 2013;310(20):2174–83.

    Article  CAS  PubMed  Google Scholar 

  88. Rennick G, Shann F, de Campo J. Cerebral herniation during bacterial meningitis in children. BMJ. 1993;306(6883):953–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  89. Akpede GO, Ambe JP. Cerebral herniation in pyogenic meningitis: prevalence and related dilemmas in emergency room populations in developing countries. Dev Med Child Neurol. 2000;42(7):462–9.

    Article  CAS  PubMed  Google Scholar 

  90. Winkler F, Kastenbauer S, Yousry TA, Maerz U, Pfister H-W. Discrepancies between brain CT imaging and severely raised intracranial pressure proven by ventriculostomy in adults with pneumococcal meningitis. J Neurol. 2002;249(9):1292–7.

    Article  PubMed  Google Scholar 

  91. Baussart B, Cheisson G, Compain M, et al. Multimodal cerebral monitoring and decompressive surgery for the treatment of severe bacterial meningitis with increased intracranial pressure. Acta Anaesthesiol Scand. 2006;50(6):762–5.

    Article  CAS  PubMed  Google Scholar 

  92. Perin A, Nascimben E, Longatti P. Decompressive craniectomy in a case of intractable intracranial hypertension due to pneumococcal meningitis. Acta Neurochir. 2008;150(8):837–42. Discussion 42.

    Article  CAS  PubMed  Google Scholar 

  93. Bordes J, Boret H, Lacroix G, Prunet B, Meaudre E, Kaiser E. Decompressive craniectomy guided by cerebral microdialysis and brain tissue oxygenation in a patient with meningitis. Acta Anaesthesiol Scand. 2011;55(1):130–3.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden

    Martin Glimaker

Authors
  1. Martin Glimaker
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Martin Glimaker .

Editor information

Editors and Affiliations

  1. UT Health-McGovern Medical School, Houston, Texas, USA

    Rodrigo Hasbun

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Glimaker, M. (2018). Community-Acquired Acute Bacterial Meningitis. In: Hasbun, R. (eds) Meningitis and Encephalitis. Springer, Cham. https://doi.org/10.1007/978-3-319-92678-0_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-92678-0_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-92677-3

  • Online ISBN: 978-3-319-92678-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation